-
1
-
-
41349099104
-
Cancer statistics, 2008
-
PMID: 18287387
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96. [PMID: 18287387]
-
(2008)
CA Cancer J Clin
, vol.58
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Murray, T.6
-
2
-
-
38049097816
-
Localized prostate cancer is rarely a fatal disease [Editorial]
-
PMID: 18185510
-
Scardino PT. Localized prostate cancer is rarely a fatal disease [Editorial]. Nat Clin Pract Urol. 2008;5:1. [PMID: 18185510]
-
(2008)
Nat Clin Pract Urol
, vol.5
, pp. 1
-
-
Scardino, P.T.1
-
3
-
-
51049104630
-
Scandinavian Prostate Cancer Group Study Number 4. Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian prostate cancer group-4 randomized trial
-
PMID: 18695132
-
Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, et al. Scandinavian Prostate Cancer Group Study Number 4. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst. 2008;100:1144-54. [PMID: 18695132]
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1144-1154
-
-
Bill-Axelson, A.1
Holmberg, L.2
Filen, F.3
Ruutu, M.4
Garmo, H.5
Busch, C.6
-
4
-
-
63249122661
-
PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial
-
PMID: 19297565
-
Andriole GL, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, et al. PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310-9. [PMID: 19297565]
-
(2009)
N Engl J Med
, vol.360
, pp. 1310-1319
-
-
Andriole, G.L.1
Grubb 3rd, R.L.2
Buys, S.S.3
Chia, D.4
Church, T.R.5
Fouad, M.N.6
-
5
-
-
63249118690
-
ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study
-
PMID: 19297566
-
Schröder FH, HugossonJ, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-8. [PMID: 19297566]
-
(2009)
N Engl J Med
, vol.360
, pp. 1320-1328
-
-
Schröder, F.H.1
Hugosson, J.2
Roobol, M.J.3
Tammela, T.L.4
Ciatto, S.5
Nelen, V.6
-
6
-
-
34948825892
-
EORTC 22911. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911
-
PMID: 17878474
-
Van der Kwast TH, Bolla M, Van Poppel H, Van Cangh P, Vekemans K, Da Pozzo L, et al; EORTC 22911. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol. 2007;25:4178-86. [PMID: 17878474]
-
(2007)
J Clin Oncol
, vol.25
, pp. 4178-4186
-
-
Van der Kwast, T.H.1
Bolla, M.2
Van Poppel, H.3
Van Cangh, P.4
Vekemans, K.5
Da Pozzo, L.6
-
7
-
-
33847414931
-
Pathologic findings at radical prostatectomy: Risk factors for failure and death
-
PMID: 17349524
-
Swanson GP, Riggs M, Hermans M. Pathologic findings at radical prostatectomy: risk factors for failure and death. Urol Oncol. 2007;25:110-4. [PMID: 17349524]
-
(2007)
Urol Oncol
, vol.25
, pp. 110-114
-
-
Swanson, G.P.1
Riggs, M.2
Hermans, M.3
-
8
-
-
59549095954
-
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial
-
PMID: 19167731
-
Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181:956-62. [PMID: 19167731]
-
(2009)
J Urol
, vol.181
, pp. 956-962
-
-
Thompson, I.M.1
Tangen, C.M.2
Paradelo, J.3
Lucia, M.S.4
Miller, G.5
Troyer, D.6
-
9
-
-
0028307641
-
Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies
-
PMID: 8037294
-
Bostwick DG. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol. 1994;18:796-803. [PMID: 8037294]
-
(1994)
Am J Surg Pathol
, vol.18
, pp. 796-803
-
-
Bostwick, D.G.1
-
10
-
-
0030916083
-
Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings
-
PMID: 9158682
-
Steinberg DM, Sauvageot J, Piantadosi S, Epstein JI. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol. 1997;21:566-76. [PMID: 9158682]
-
(1997)
Am J Surg Pathol
, vol.21
, pp. 566-576
-
-
Steinberg, D.M.1
Sauvageot, J.2
Piantadosi, S.3
Epstein, J.I.4
-
11
-
-
0032212356
-
Independent origin ofmultiple foci ofprostatic intraepithelial neoplasia: Comparison with matched foci of prostate carcinoma
-
PMID: 9806659
-
Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, et al. Independent origin ofmultiple foci ofprostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer. 1998;83:1995-2002. [PMID: 9806659]
-
(1998)
Cancer
, vol.83
, pp. 1995-2002
-
-
Bostwick, D.G.1
Shan, A.2
Qian, J.3
Darson, M.4
Maihle, N.J.5
Jenkins, R.B.6
-
12
-
-
65649140882
-
Molecular markers and death from prostate cancer
-
Concato J, Jain D, Uchio E, Risch H, Li WW, Wells CK. Molecular markers and death from prostate cancer. Ann Intern Med. 2009;150:595-603.
-
(2009)
Ann Intern Med
, vol.150
, pp. 595-603
-
-
Concato, J.1
Jain, D.2
Uchio, E.3
Risch, H.4
Li, W.W.5
Wells, C.K.6
-
13
-
-
0034186628
-
Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate
-
PMID: 10792093
-
Krupski T, Petroni GR, Frierson HF Jr, Theodorescu JU. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate. Urology. 2000;55:743-9. [PMID: 10792093]
-
(2000)
Urology
, vol.55
, pp. 743-749
-
-
Krupski, T.1
Petroni, G.R.2
Frierson Jr, H.F.3
Theodorescu, J.U.4
-
14
-
-
61449137045
-
What will the emperor say?: Screening for prostate cancer as of 2008
-
PMID: 19197166
-
Concato J. What will the emperor say?: screening for prostate cancer as of 2008. Cancer J. 2009;15:7-12. [PMID: 19197166]
-
(2009)
Cancer J
, vol.15
, pp. 7-12
-
-
Concato, J.1
-
15
-
-
64949135826
-
Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context
-
PMID: 19276453
-
Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009;101:374-83. [PMID: 19276453]
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 374-383
-
-
Draisma, G.1
Etzioni, R.2
Tsodikov, A.3
Mariotto, A.4
Wever, E.5
Gulati, R.6
|